Suppr超能文献

[异环磷酰胺抗癌化疗后观察到室性早搏]

[Ventricular premature contraction observed after anti-cancer chemotherapy with ifosfamide].

作者信息

Takahashi J, Kawashima R, Abe Y, Fukuda H, Kubota K, Yamada K, Sato T

机构信息

Dept. of Nuclear Medicine and Radiology, Tohoku University.

出版信息

Gan To Kagaku Ryoho. 1994 Aug;21(10):1681-4.

PMID:7520222
Abstract

We encountered 3 cases of ventricule premature contraction (VPC) after anti-cancer chemotherapy with ifosfamide (IFM). These cases were administered IFM of more than 2 g/body/day for 3 days, and they were more than 70 years old. They had no cardiovascular disorder before the chemotherapy. Among them, 1 case who received a total dose of 15.0 g of IFM showed severe VPC. She had also received a total dose of 155 mg of doxorubicin (ADM) in earlier treatment. There was also 1 case, whose VPC was aggravated after anti-cancer chemotherapy with IFM. He had dilated cardiomyopathy and had already showed frequent VPC before the chemotherapy. His VPC became more frequent after the chemotherapy. IFM was a common agent among the anti-cancer agents used in these cases. We must be careful for the occurrence of VPC when more than 2 g/body/day of IFM is administered to patients more than 70 years old. An increase in the total dose of IFM or former ADM may cause severe VPC. When IFM is given a patient with VPC, the existing VPC may be aggravated.

摘要

我们遇到了3例使用异环磷酰胺(IFM)进行抗癌化疗后出现室性早搏(VPC)的病例。这些病例接受了每天每体表面积超过2 g的IFM治疗3天,且年龄均超过70岁。化疗前他们没有心血管疾病。其中,1例接受了总量为15.0 g的IFM,出现了严重的室性早搏。她在早期治疗中还接受了总量为155 mg的阿霉素(ADM)。还有1例,在使用IFM进行抗癌化疗后室性早搏加重。他患有扩张型心肌病,化疗前就已经出现频发室性早搏。化疗后他的室性早搏变得更加频繁。IFM是这些病例中使用的抗癌药物中的常用药物。当给70岁以上的患者每天每体表面积使用超过2 g的IFM时,我们必须注意室性早搏的发生。IFM总量的增加或既往使用ADM可能会导致严重的室性早搏。当给有室性早搏的患者使用IFM时,现有的室性早搏可能会加重。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验